tumoron
Conditions
Interventions
control group:Conventional Western antiemetic regimen and Placebo treatment
treatment group:Conventional Western antiemetic regimen and Gaomo therapy
Sponsors
Beijing University of Chinese Medicine Dongzhimen Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Confirmed diagnosis of malignant tumor with TNM staging at phase I-IV; 2) Received chemotherapy containing platinum-based drugs; 3) Developed gastrointestinal reactions (nausea vomiting anorexia etc.) post-chemotherapy; 4) Karnofsky Performance Status (KPS) score =60; 5) No significant abnormalities in heart liver kidney or other organ functions; 6) Aged 18-80 years (inclusive) regardless of gender; 7) Participants provided informed consent and voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Pregnancy or lactation; 2) Cognitive impairment; 3) Uncontrolled infectious diseases; 4) Hypersensitivity to the drug(s); 5) Poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Karnofsky Performance Status (KPS) Score;Gastrointestinal Adverse Reactions Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM Syndrome Score; | — |
Countries
China
Contacts
Public ContactShi Yi
Beijing University of Chinese Medicine Dongzhimen Hospital
Outcome results
None listed